vs

Side-by-side financial comparison of NATIONAL BANKSHARES INC (NKSH) and NeuroPace Inc (NPCE). Click either name above to swap in a different company.

NeuroPace Inc is the larger business by last-quarter revenue ($26.6M vs $15.3M, roughly 1.7× NATIONAL BANKSHARES INC). NATIONAL BANKSHARES INC runs the higher net margin — 38.5% vs -10.3%, a 48.8% gap on every dollar of revenue. On growth, NATIONAL BANKSHARES INC posted the faster year-over-year revenue change (24.7% vs 23.9%). NATIONAL BANKSHARES INC produced more free cash flow last quarter ($15.2M vs $409.0K). Over the past eight quarters, NeuroPace Inc's revenue compounded faster (21.1% CAGR vs 20.9%).

Nicolet Bankshares, Inc. is a U.S. regional bank holding company based in Green Bay, Wisconsin. They are the parent company of Nicolet National Bank, the second largest Wisconsin-based bank.

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

NKSH vs NPCE — Head-to-Head

Bigger by revenue
NPCE
NPCE
1.7× larger
NPCE
$26.6M
$15.3M
NKSH
Growing faster (revenue YoY)
NKSH
NKSH
+0.8% gap
NKSH
24.7%
23.9%
NPCE
Higher net margin
NKSH
NKSH
48.8% more per $
NKSH
38.5%
-10.3%
NPCE
More free cash flow
NKSH
NKSH
$14.7M more FCF
NKSH
$15.2M
$409.0K
NPCE
Faster 2-yr revenue CAGR
NPCE
NPCE
Annualised
NPCE
21.1%
20.9%
NKSH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NKSH
NKSH
NPCE
NPCE
Revenue
$15.3M
$26.6M
Net Profit
$5.9M
$-2.7M
Gross Margin
77.4%
Operating Margin
47.4%
-6.6%
Net Margin
38.5%
-10.3%
Revenue YoY
24.7%
23.9%
Net Profit YoY
91.0%
48.0%
EPS (diluted)
$0.93
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NKSH
NKSH
NPCE
NPCE
Q4 25
$15.3M
$26.6M
Q3 25
$14.2M
$27.4M
Q2 25
$13.3M
$23.5M
Q1 25
$12.8M
$22.5M
Q4 24
$12.2M
$21.5M
Q3 24
$11.7M
$21.1M
Q2 24
$10.9M
$19.3M
Q1 24
$10.4M
$18.1M
Net Profit
NKSH
NKSH
NPCE
NPCE
Q4 25
$5.9M
$-2.7M
Q3 25
$4.4M
$-3.5M
Q2 25
$2.3M
$-8.7M
Q1 25
$3.2M
$-6.6M
Q4 24
$3.1M
$-5.3M
Q3 24
$2.7M
$-5.5M
Q2 24
$-307.0K
$-7.5M
Q1 24
$2.2M
$-8.9M
Gross Margin
NKSH
NKSH
NPCE
NPCE
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
73.2%
Q2 24
73.4%
Q1 24
73.6%
Operating Margin
NKSH
NKSH
NPCE
NPCE
Q4 25
47.4%
-6.6%
Q3 25
37.9%
-9.5%
Q2 25
20.0%
-29.0%
Q1 25
30.5%
-22.9%
Q4 24
30.1%
-17.0%
Q3 24
27.5%
-20.1%
Q2 24
-4.4%
-32.4%
Q1 24
25.8%
-41.6%
Net Margin
NKSH
NKSH
NPCE
NPCE
Q4 25
38.5%
-10.3%
Q3 25
31.1%
-12.8%
Q2 25
17.2%
-36.8%
Q1 25
25.3%
-29.3%
Q4 24
25.1%
-24.5%
Q3 24
22.8%
-25.9%
Q2 24
-2.8%
-39.0%
Q1 24
20.8%
-49.2%
EPS (diluted)
NKSH
NKSH
NPCE
NPCE
Q4 25
$0.93
$-0.08
Q3 25
$0.69
$-0.11
Q2 25
$0.36
$-0.26
Q1 25
$0.51
$-0.21
Q4 24
$0.50
$-0.16
Q3 24
$0.42
$-0.19
Q2 24
$-0.05
$-0.26
Q1 24
$0.37
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NKSH
NKSH
NPCE
NPCE
Cash + ST InvestmentsLiquidity on hand
$59.3M
$61.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$184.9M
$19.0M
Total Assets
$1.8B
$105.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NKSH
NKSH
NPCE
NPCE
Q4 25
$59.3M
$61.1M
Q3 25
$42.3M
$60.0M
Q2 25
$92.8M
$62.1M
Q1 25
$122.5M
$66.3M
Q4 24
$108.1M
$52.8M
Q3 24
$49.8M
$56.8M
Q2 24
$98.9M
$55.5M
Q1 24
$121.2M
$58.9M
Stockholders' Equity
NKSH
NKSH
NPCE
NPCE
Q4 25
$184.9M
$19.0M
Q3 25
$179.2M
$18.5M
Q2 25
$168.7M
$19.4M
Q1 25
$167.3M
$24.3M
Q4 24
$156.4M
$8.0M
Q3 24
$167.8M
$9.8M
Q2 24
$149.0M
$9.9M
Q1 24
$139.4M
$14.3M
Total Assets
NKSH
NKSH
NPCE
NPCE
Q4 25
$1.8B
$105.6M
Q3 25
$1.8B
$107.3M
Q2 25
$1.8B
$106.1M
Q1 25
$1.8B
$110.2M
Q4 24
$1.8B
$94.6M
Q3 24
$1.8B
$96.3M
Q2 24
$1.8B
$94.4M
Q1 24
$1.7B
$98.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NKSH
NKSH
NPCE
NPCE
Operating Cash FlowLast quarter
$17.9M
$506.0K
Free Cash FlowOCF − Capex
$15.2M
$409.0K
FCF MarginFCF / Revenue
99.2%
1.5%
Capex IntensityCapex / Revenue
17.9%
0.4%
Cash ConversionOCF / Net Profit
3.04×
TTM Free Cash FlowTrailing 4 quarters
$23.6M
$-11.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NKSH
NKSH
NPCE
NPCE
Q4 25
$17.9M
$506.0K
Q3 25
$6.1M
$-1.9M
Q2 25
$2.1M
$-2.1M
Q1 25
$2.6M
$-7.5M
Q4 24
$9.4M
$-4.8M
Q3 24
$3.1M
$-1.7M
Q2 24
$-3.0M
$-3.9M
Q1 24
$3.8M
$-7.5M
Free Cash Flow
NKSH
NKSH
NPCE
NPCE
Q4 25
$15.2M
$409.0K
Q3 25
$5.3M
$-2.0M
Q2 25
$1.5M
$-2.3M
Q1 25
$1.6M
$-7.5M
Q4 24
$6.2M
$-4.8M
Q3 24
$2.2M
$-1.8M
Q2 24
$-4.0M
$-4.0M
Q1 24
$3.5M
$-7.6M
FCF Margin
NKSH
NKSH
NPCE
NPCE
Q4 25
99.2%
1.5%
Q3 25
37.4%
-7.2%
Q2 25
11.5%
-9.6%
Q1 25
12.5%
-33.4%
Q4 24
50.5%
-22.5%
Q3 24
18.5%
-8.7%
Q2 24
-36.3%
-20.6%
Q1 24
33.8%
-42.1%
Capex Intensity
NKSH
NKSH
NPCE
NPCE
Q4 25
17.9%
0.4%
Q3 25
5.6%
0.1%
Q2 25
4.1%
0.7%
Q1 25
7.5%
0.2%
Q4 24
26.6%
0.2%
Q3 24
8.3%
0.5%
Q2 24
9.3%
0.3%
Q1 24
3.0%
0.6%
Cash Conversion
NKSH
NKSH
NPCE
NPCE
Q4 25
3.04×
Q3 25
1.38×
Q2 25
0.90×
Q1 25
0.79×
Q4 24
3.07×
Q3 24
1.17×
Q2 24
Q1 24
1.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons